The British Association of Aesthetic Plastic Surgeons (BAAPS) has released its 2023 audit which highlights a significant decline in both surgical and non-surgical aesthetic treatments.1
The total amount of surgical procedures performed by BAAPS surgeons fell 16% for both men and women in 2023, and botulinum toxin and dermal filler treatments went down 11% in 2023.1 This is not the first time a drop in cosmetic surgery has been reported, with market research company RARE:Group Consulting noting that surgical aesthetic procedures fell at an average of 31% last year.2
Again, this coincides with the findings for non-surgical treatments, which showed the dermal filler and botulinum toxin markets shrunk by 31% and 16% in the last 12 months.2 So, why might this be occurring, and what can the UK medical aesthetic specialty do about it?
We spoke to Miss Nora Nugent, vice president of BAAPS, and Mr Naveen Cavale, national secretary and social media chair of the International Society of Aesthetic Plastic Surgery, to get their advice…
